This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Clorox (CLX) Receives a Hold from TD Cowen
TD Cowen analyst Robert Moskow maintained a Hold rating on Clorox today and set a price target of $98.00.
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Moskow is a 2-star analyst with an average return of 0.5% and a 44.61% success rate. Moskow covers the Consumer Defensive sector, focusing on stocks such as JM Smucker, Church & Dwight, and Clorox.
Clorox has an analyst consensus of Hold, with a price target consensus of $115.69.
Based on Clorox’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.67 billion and a net profit of $157 million. In comparison, last year the company earned a revenue of $1.69 billion and had a net profit of $193 million
Read More on CLX:
Disclaimer & DisclosureReport an Issue
- Clorox price target lowered to $98 from $111 at TD Cowen
- Clorox price target lowered to $101 from $112 at Deutsche Bank
- Clorox Secures New Credit Facilities for GOJO Acquisition
- Clorox: Margin Recovery Achieved but Ambitious Growth Targets Keep Rating at Hold
- Clorox price target raised to $124 from $112 at BofA
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
